Finance

Beta
Lists
RNTX:NASDAQ
Rein Therapeutics Inc
$0.92
0.00%
(0.00) 1D
$0.92
+0.28% (+0.0026)
After hours
Closed: Jun 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNTX...
Open
$0.91
High
$0.97
Low
$0.89
Mkt. cap
78.76M
Avg. vol.
1.18M
Volume
1.00
52-wk high
$2.18
52-wk low
$0.89
EPS
-$1.78
Beta
1.35
Shares outstanding
85.54M
No. of employees
10
Open
$0.91
High
$0.97
Low
$0.89
Mkt. cap
78.76M
Avg. vol.
1.18M
Volume
1.00
52-wk high
$2.18
52-wk low
$0.89
EPS
-$1.78
Beta
1.35
Shares outstanding
85.54M
No. of employees
10
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to RNTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for RNTX in the last 3 months.
Highest
Current $0.92
$8.00 (+769.19%)
Average
$8.00 (+769.19%)
Lowest
$8.00 (+769.19%)
News stories
From sources across the web
About Rein Therapeutics Inc
CEO-
Employees10
Founded2001
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitereintx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.29M
1.68M
2.00M
3.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.58M
3.81M
1.96M
2.16M
Operating expense
6.87M
5.49M
3.96M
5.23M
Total operating expenses
6.87M
5.49M
3.96M
5.23M
Operating income
-6.87M
-5.49M
-3.96M
-5.23M
Other non operating income
49.00K
-89.00K
-20.00K
-608.00K
EBT including unusual items
-6.82M
-5.58M
-32.68M
-5.84M
EBT excluding unusual items
-6.82M
-5.58M
-3.98M
-5.84M
Income tax expense
-
-
-712.00K
-
Effective tax rate
-
-
2.18%
-
Other operating expenses
-
-
-
-
Net income
-6.82M
-5.58M
-31.97M
-5.84M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.87M
-5.49M
-3.96M
-5.23M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer